fda glp-1 compounding enforcement september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Why the FDA Issued 30

Does semaglutide affect how my body processes carbohydrates like rice

However, longer isn't always better

Ensure you have a secure method to access and track your prescription information

The primary factors driving the growth of the nutraceutical and functional food markets are the increasing prevalence of obesity, diabetes, eye health problems, cardiovascular diseases, changing food consumption patterns in developing markets, growing interest in preventive medicine, and growing demand for multivitamins

Chirositol is standardised, ensuring a consistent composition from batch to batch

AOD-9604 has preclinical + limited clinical